Antipsychotic effects of verapamil in schizophrenia.

Antipsychotic effects of verapamil in schizophrenia.

Price W A

The Hillside journal of clinical psychiatry

1987

1987

The antipsychotic effects of verapamil were tested in a double-blind, placebo-controlled, randomized study in 18 patients who met Research Diagnostic Criteria for acute schizophrenia. The antipsychotic effect of verapamil as measured by the Bunney-Hamburg Global Rating Scale were equal to those of haloperidol. Both verapamil and haloperidol were superior to placebo in decreasing psychotic symptoms. The results indicate that verapamil may have clinical utility in the treatment of schizophrenia.

Adult; Female; Humans; Male; Middle Aged; Random Allocation; Double-Blind Method; Clinical Trials as Topic; Haloperidol/therapeutic use; Schizophrenia/*drug therapy; Verapamil/*therapeutic use

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

225–230

2

9